시장보고서
상품코드
1668202

성병 자가 검사 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 용도별(CT/NG 검사, 매독 검사, HIV 검사, 기타), 지역별, 경쟁별(2020-2030년)

STD Self-Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (CT/NG Testing, Syphilis Testing, HIV Testing, Others), By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 187 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 성병 자가 검사 시장은 2024년에 12억 1,000만 달러로 평가되며, 예측 기간 중 CAGR 7.43%를 반영하고, 2030년에는 18억 6,000만 달러에 달할 것으로 예측됩니다.

성병(STD) 자가 검사 시장은성 건강에 대한 인식 증가, 진단 기술의 발전, 프라이버시 및 기존 검사법을 둘러싼 편견에 대한 우려 증가 등을 배경으로 최근 수년간 괄목할 만한 성장세를 보이고 있습니다. 자가 검사 키트는 개인에게 개인 검사의 편의성을 제공하고 진단 및 조기 개입에 대한 장벽을 낮춥니다. HIV, 클라미디아, 임질, 매독, 인간유두종바이러스(HPV) 등 감염성 질환에 대한 접근성, 사용 편의성, 신뢰성으로 인해 이러한 키트 수요가 증가하고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 12억 1,000만 달러
시장 규모 : 2030년 18억 6,000만 달러
CAGR: 2025-2030년 7.43%
급성장 부문 CT/NG 검사
최대 시장 북미

성병 자가 검사 시장의 주요 촉진요인은 전 세계에서 성병(STI)의 확산입니다. 세계보건기구(WHO)에 따르면 15세에서 49세 사이의 개인 중 매일 100만 명 이상이 치료 가능한 STI에 감염되고 있으며, 그 중 대부분은 무증상입니다.

디지털 건강 솔루션과 원격의료 서비스의 도입이 증가함에 따라 특히 원격지나 의료 서비스가 부족한 지역에서 자가 검사 키트의 보급과 사용이 더욱 촉진되고 있습니다. 또한성 건강 교육 및 자가 테스트 옵션의 가용성을 장려하는 정부의 구상은 시장 확대에 도움이 되고 있으며, 성병 검사를 위해 의료기관을 방문하는 것에 대한 편견도 자가 테스트 키트에 대한 선호도를 높이는 데 기여하고 있습니다. 많은 개인, 특히 젊은 층과 보수적인 사회 구성원들은 직접 병원을 방문하는 것보다 집에서 진단할 수 있는 키트가 더 안전하다고 느낍니다. 이러한 소비자 행동의 변화로 인해 시장 업체들은 혁신적이고 사용하기 편리하며 정확도가 높은 자가 진단 제품을 개발하기 위해 노력하고 있습니다.

진단 툴의 기술 발전으로 키트의 정확성과 신뢰성이 크게 향상되었습니다. 핵산 증폭 검사(NAAT), 측방유동 어세이, 스마트폰 기반 진단 툴와 같은 기술 혁신으로 인해 가정에서의 검사 효율성이 향상되었습니다. 대부분의 최신 자가 진단 키트는 단계별 안내, 결과 해석, 원격의료 상담에 대한 액세스를 제공하는 모바일 애플리케이션을 통합하고 있습니다. 이러한 발전은 사용자 경험을 향상시킬 뿐만 아니라 적시에 진단과 치료에 기여하고 감염 확산을 억제하는 데 도움이 됩니다.

주요 시장 성장 촉진요인

성병 유병률 증가

주요 시장이 해결해야 할 과제

규제 및 컴플라이언스 과제

정확성과 신뢰성에 대한 우려

주요 시장 동향

재택 진단 솔루션 도입 증가

검사 키트의 기술적 진보

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 COVID-19가 세계의 성병 자가 검사 시장에 미치는 영향

제5장 세계의 성병 자가 검사 시장 전망

  • 시장 규모·예측
    • 금액별
  • 시장 점유율·예측
    • 용도별(CT/NG 검사, 매독 검사, HIV 검사, 기타)
    • 지역별
    • 기업별(2024)
  • 시장 맵

제6장 북미의 성병 자가 검사 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 북미 : 국가별 분석
    • 멕시코
    • 캐나다

제7장 유럽의 성병 자가 검사 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 유럽 : 국가별 분석
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제8장 아시아태평양의 성병 자가 검사 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 아시아태평양 : 국가별 분석
    • 인도
    • 한국
    • 일본
    • 호주

제9장 남미의 성병 자가 검사 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 남미 : 국가별 분석
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 성병 자가 검사 시장 전망

  • 시장 규모·예측
  • 시장 점유율·예측
  • 중동 및 아프리카 : 국가별 분석
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 합병과 인수(있는 경우)
  • 애플리케이션 기동(있는 경우)
  • 최근 동향

제13장 세계의 성병 자가 검사 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여의 가능성
  • 공급업체의 힘
  • 고객의 힘
  • 대체품의 위협

제15장 경쟁 구도

  • OraSure Technologies, Inc.
  • Selfdiagnostics Deutschland GmbH
  • Wondfo BIOTECH CO., LTD.
  • bioLytical Laboratories Inc.
  • autotest VIH
  • Abbott Laboratories
  • Visby Medical Inc.
  • PrivaPath Diagnostics(LetsGetChecked)
  • NOWDiagnostics, Inc.

제16장 전략적 제안

제17장 조사회사 소개·면책사항

KSA 25.04.08

The global STD self-testing market was valued at USD 1.21 billion in 2024 and is projected to reach USD 1.86 billion by 2030, reflecting a compound annual growth rate (CAGR) of 7.43% during the forecast period. The market for self-testing of sexually transmitted diseases (STDs) has seen notable growth in recent years, driven by heightened awareness of sexual health, advancements in diagnostic technology, and increasing concerns regarding privacy and the stigma surrounding traditional testing methods. Self-testing kits offer individuals the convenience of private testing, reducing barriers to diagnosis and early intervention. The demand for these kits is growing due to their accessibility, ease of use, and reliability in detecting infections such as HIV, chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV).

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.21 Billion
Market Size 2030USD 1.86 Billion
CAGR 2025-20307.43%
Fastest Growing SegmentCT/NG Testing
Largest MarketNorth America

A key driver of the STD self-testing market is the rising prevalence of sexually transmitted infections (STIs) globally. According to the World Health Organization (WHO), over one million curable STIs are contracted daily worldwide among individuals aged 15 to 49, with the majority of these being asymptomatic.

The increasing adoption of digital health solutions and telemedicine services has further facilitated the distribution and use of self-testing kits, particularly in remote or underserved areas. Additionally, government initiatives promoting sexual health education and the availability of self-testing options have been instrumental in expanding the market. The stigma associated with visiting healthcare facilities for STD testing has also led to a growing preference for self-testing kits. Many individuals, especially younger adults and those in more conservative societies, feel more comfortable using at-home diagnostic solutions rather than undergoing in-person consultations. This shift in consumer behavior has prompted market players to develop innovative, user-friendly, and highly accurate self-testing products.

Technological advancements in diagnostic tools have significantly enhanced the accuracy and reliability of STD self-testing kits. Innovations such as nucleic acid amplification tests (NAATs), lateral flow assays, and smartphone-based diagnostic tools have improved the efficiency of at-home testing. Many modern self-testing kits now integrate mobile applications that provide step-by-step guidance, results interpretation, and access to telehealth consultations. These advancements not only enhance the user experience but also contribute to timely diagnoses and treatment, reducing the spread of infections.

Key Market Drivers

Increasing Prevalence of Sexually Transmitted Diseases

The global market for STD self-testing is witnessing rapid growth, primarily fueled by the rising prevalence of STDs worldwide. Increased awareness of sexual health, the convenience of self-testing kits, and advancements in diagnostic technology are key factors contributing to market expansion. With governments and health organizations emphasizing early detection and prevention, demand for self-testing solutions has surged. The growing burden of STDs, including chlamydia, gonorrhea, syphilis, and HIV, highlights the need for accessible and discreet testing options. Self-testing kits provide a convenient, private, and efficient method for individuals to screen for infections without visiting a healthcare facility, making them an appealing alternative to traditional clinical testing.

Advancements in diagnostic technologies have also fueled the adoption of STD self-testing kits. Modern kits now incorporate features such as smartphone connectivity, rapid detection, and high accuracy, ensuring reliable results. Many kits are now designed to detect multiple infections in a single test, reducing the need for separate screenings and enhancing efficiency. The availability of easy-to-use, over-the-counter test kits has further strengthened the market by enabling individuals to take proactive measures for their sexual health.

Governments and non-governmental organizations (NGOs) are increasingly launching public health campaigns to raise awareness and combat the spread of STDs, further driving market growth. Various healthcare policies supporting self-testing, especially in regions with high STD prevalence, have improved access to these kits. For example, the U.S. Centers for Disease Control and Prevention (CDC) and the UK National Health Service (NHS) have promoted home-based testing to encourage early detection and reduce transmission rates.

The expansion of e-commerce and digital healthcare platforms has also played a significant role in making STD self-testing kits more accessible. Online platforms provide discreet purchasing options, addressing concerns about privacy and stigma. The integration of telemedicine with self-testing kits enhances consumer confidence by enabling virtual consultations with healthcare professionals for result interpretation and follow-up guidance.

Key Market Challenges

Regulatory and Compliance Challenges

A major challenge in the STD self-testing market is the complex regulatory landscape across various regions. Governments and health authorities have stringent guidelines to ensure the accuracy, reliability, and safety of self-testing kits. The variation in regulatory approvals complicates the standardization of products globally, leading to delays in market entry and increased compliance costs. Additionally, some countries do not yet recognize self-testing as a valid diagnostic method, limiting its accessibility and adoption.

Concerns Over Accuracy and Reliability

Another significant challenge is the accuracy and reliability of self-testing kits. While technological advancements have improved the sensitivity and specificity of these tests, there remains a risk of false positives or false negatives, which could result in misdiagnosis. This could lead to delayed treatment or unnecessary anxiety for users. Furthermore, some healthcare professionals express concerns about the lack of professional oversight, as users may misinterpret results without proper guidance, thereby reducing the effectiveness of self-testing.

Key Market Trends

Increased Adoption of At-Home Diagnostic Solutions

There has been a growing preference for at-home diagnostic solutions, particularly after the COVID-19 pandemic, which accelerated the trend of remote healthcare services. Consumers are increasingly comfortable using self-testing kits for various medical conditions, including STDs. The convenience of obtaining private results without the need for a clinic or laboratory visit has contributed to the rising demand for these products.

Technological Advancements in Testing Kits

Technological innovations have greatly improved the accuracy, reliability, and usability of STD self-testing kits. Modern kits incorporate advanced diagnostic technologies such as nucleic acid amplification tests (NAATs) and lateral flow assays, offering precise results. Furthermore, smartphone-based applications integrated with self-testing devices enable users to interpret results easily and receive guidance on the next steps.

Key Market Players

  • OraSure Technologies, Inc.
  • Selfdiagnostics Deutschland GmbH
  • Wondfo BIOTECH CO., LTD.
  • bioLytical Laboratories
  • autotest VIH Inc.
  • Abbott Laboratories
  • Visby Medical Inc.
  • PrivaPath Diagnostics (LetsGetChecked)
  • NOWDiagnostics Inc.

Report Scope

This report segments the global STD self-testing market and covers industry trends in detail:

By Application:

  • CT/NG Testing
  • Syphilis Testing
  • HIV Testing
  • Others

By Region:

  • North America (United States, Canada, Mexico)
  • Europe (France, United Kingdom, Italy, Germany, Spain)
  • Asia Pacific (China, India, Japan, Australia, South Korea)
  • South America (Brazil, Argentina, Colombia)
  • Middle East & Africa (South Africa, Saudi Arabia, UAE)

Competitive Landscape

The report includes detailed company profiles of major players in the global STD self-testing market.

Available Customizations:

The report offers customization options tailored to specific company needs, including additional analysis and profiling of up to five market players.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Applications
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global STD Self-Testing Market

5. Global STD Self-Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (CT/NG Testing, Syphilis Testing, HIV Testing, Others)
    • 5.2.2. By Region
    • 5.2.3. By Company (2024)
  • 5.3. Market Map

6. North America STD Self-Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States STD Self-Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
    • 6.3.2. Mexico STD Self-Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
    • 6.3.3. Canada STD Self-Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application

7. Europe STD Self-Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France STD Self-Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
    • 7.3.2. Germany STD Self-Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
    • 7.3.3. United Kingdom STD Self-Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
    • 7.3.4. Italy STD Self-Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
    • 7.3.5. Spain STD Self-Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application

8. Asia Pacific STD Self-Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China STD Self-Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
    • 8.3.2. India STD Self-Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
    • 8.3.3. South Korea STD Self-Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
    • 8.3.4. Japan STD Self-Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
    • 8.3.5. Australia STD Self-Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application

9. South America STD Self-Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil STD Self-Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
    • 9.3.2. Argentina STD Self-Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
    • 9.3.3. Colombia STD Self-Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application

10. Middle East and Africa STD Self-Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa STD Self-Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
    • 10.3.2. Saudi Arabia STD Self-Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
    • 10.3.3. UAE STD Self-Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Application Launches (If Any)
  • 12.3. Recent Developments

13. Global STD Self-Testing Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. OraSure Technologies, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Selfdiagnostics Deutschland GmbH
  • 15.3. Wondfo BIOTECH CO., LTD.
  • 15.4. bioLytical Laboratories Inc.
  • 15.5. autotest VIH
  • 15.6. Abbott Laboratories
  • 15.7. Visby Medical Inc.
  • 15.8. PrivaPath Diagnostics (LetsGetChecked)
  • 15.9. NOWDiagnostics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제